Dr. Takafumi Yanagisawa is a Lecturer in the Department of Urology at Jikei University School of Medicine, Tokyo, Japan. His clinical and research expertise lies in urologic oncology, particularly in systemic therapy for urological cancers, robotic surgery, and kidney transplantation. Dr. Yanagisawa has been instrumental in advancing evidence on en bloc transurethral resection for bladder tumors, as well as systemic treatments for advanced prostate, urothelial, and renal cell carcinomas. He has led numerous high-impact meta-analyses and real-world data studies, with recent work focusing on PSMA theranostics and immunotherapy for muscle-invasive and metastatic disease. He has published more than 200 peer-reviewed articles, including 45 as the first author, in leading international journals. He has been recognized internationally with awards such as the Best Researcher Award from the Medical University of Vienna and is frequently invited to speak at global congresses. Dr. Yanagisawa also contributes to academic training initiatives across Asia and Europe.